News
Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as ...
U.S. President Donald Trump said on Sunday he would sign an executive order that he said would reduce prescription drug and ...
WeightWatchers filed for bankruptcy on Tuesday as Americans shunned its offerings in favor of Novo and Lilly drugs and copies ...
Norway's wealth fund, the world's largest, has sold all its fixed income investments in Mexican state oil firm Pemex, it said ...
Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.
For Reuters Pharma Europe 2025, pharmaphorum is providing coverage courtesy NAVLIN Daily, a pricing and market access insights report from EVERSANA (pharmaphorum's parent company). You can see the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results